Clinical Trial

Performance of Amino Acid Positons Emission Tomography in Brain Metastases

Study acronym: DYNAMET
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Differentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-24.
Trial Details
NCT Number NCT07676448
Lead Sponsor Central Hospital, Nancy, France
Conditions PET-CT
Enrollment 80 participants
Start Date 2026-08-05
Primary Completion 2026-09-03 (estimated)
Study Completion 2026-11-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-17